Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5641)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vasekar M, Liu X, Zheng H, Belani CP. Targeted immunotherapy for non-small cell lung cancer. World J Clin Oncol 2014; 5(2): 39-47 [PMID: 24829850 DOI: 10.5306/wjco.v5.i2.39] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/39.htm |
| Number | Citing Articles |
| 1 |
Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng Tseng, Wen-Feng Fang, Chin-Chou Wang, Yu-Hsiu Chung, Yi-Hsi Wang, Mao-Chang Su, Kuo-Tung Huang, Hung-cheng Chen, Meng-Chih Lin. The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitors. Lung Cancer 2016; 93: 47 doi: 10.1016/j.lungcan.2016.01.001
|
| 2 |
WenJia Wang, SiHao Qin, Lei Zhao. Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation. Biomedicine & Pharmacotherapy 2015; 69: 18 doi: 10.1016/j.biopha.2014.10.026
|
| 3 |
Xue-Tao Li, Zhi-Yan Zhou, Ying Jiang, Mei-Li He, Lian-Qun Jia, Lin Zhao, Lan Cheng, Tian-Zhu Jia. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. Journal of Drug Targeting 2015; 23(3): 232 doi: 10.3109/1061186X.2014.979829
|
| 4 |
Xue-tao Li, Mei-li He, Zhi-yan Zhou, Ying Jiang, Lan Cheng. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation. International Journal of Pharmaceutics 2015; 487(1-2): 223 doi: 10.1016/j.ijpharm.2015.04.035
|
| 5 |
|
| 6 |
Mohammad Hojjat-Farsangi. Novel and emerging targeted-based cancer therapy agents and methods. Tumor Biology 2015; 36(2): 543 doi: 10.1007/s13277-015-3184-x
|
| 7 |
Priyanka Khanna, Normand Blais, Pierre-Olivier Gaudreau, Luis Corrales-Rodriguez. Immunotherapy Comes of Age in Lung Cancer. Clinical Lung Cancer 2017; 18(1): 13 doi: 10.1016/j.cllc.2016.06.006
|